Assertio Therapeutics

We are Assertio — a dynamic, proactive, and compassionate pharmaceutical company centered on the goal of improving patient care. Previously recognized as Depomed, we have restructured our organization with a current emphasis on three FDA-approved products in our primary fields of neurology, orphan, and specialized medications, while continuously seeking out, licensing, and creating new products that provide improved choices for patients who may have limited access to existing treatments.